Brief: Hightide Therapeutics Says FY Loss Attributable RMB939.3 Million
27/03/2024 11:58
March 27 (Reuters) - HighTide Therapeutics Inc
2511.HK :
* FY LOSS ATTRIBUTABLE RMB939.3 MILLION VERSUS LOSS RMB190.2
MILLION
Further company coverage: 2511.HK
Recent news on HighTide Therapeutics
See all newsBrief: Hightide Therapeutics To Issue Up To 99 Million New Shares At Hk$2.28 Per Share
Brief: Hightide Therapeutics Says Co And Individual Terminate Loan Agreement With Immediate Effect
Brief: Hightide Therapeutics Enters Loan Agreement Up To HK$15 Million
Brief: HighTide Therapeutics Says NMPA China Accepts New Drug Application For HTD1801
Brief: Hightide Therapeutics Posts HY Loss Attributable Of RMB120.3 Mln